6-Amino-1,4-dihydroquinoxaline-2,3-dione, 98.31%, 25g

8-Bromo-3,4-dihydro-1H-benzo[e][1,4]diazepin-5(2H)-one, 97.0%, 500mg

1-(2-Chloro-6-methoxyphenyl)ethanone, 95.0%, 5g

2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethoxy)aniline, 95.0%, 250mg

[4-(methoxymethoxy)phenyl](pyridin-2-yl)methanone, 95.0%, 5g

5-FLUORO-4-METHOXY-1H-INDAZOL-3-AMINE, 95.0%, 250mg

9,10-Dibromo-2-Phenylanthracene, 98%, 1g

2-Butanol, min 98.5%, for synthesis, 1L, glass packaging

[2-(Pyrrolidin-1-yl)pyridin-4-yl]methanol, 100mg

(S)-2-Chloro-1-(3,4-difluorophenyl)ethanol, 98%, 5g

2-Allyl-5,5-dimethyl-1,3,2-dioxaborinane (stabilized with Phenothiazine)>98.0%(GC)(T)5g

Ethyl (3-((m-tolylcarbamoyl)oxy)phenyl)carbamate, 97%, 1g

6-METHOXY-1H-INDAZOLE-3-CARBOXYLIC ACID, 95%, 1g